ALTERED BONE CELL FUNCTION IN OSTEOPETROSIS

Pubblicazioni Scientifiche

• 2002 CALCIFIED TISSUE INTERNATIONAL

  The role of the AlphaVbeta3 integrin in the development of osteolytic bone metastases: A pharmacological target for alternative therapy?

• 2000 JOURNAL OF CELL BIOLOGY

  Decreased c-Src expression enhances osteoblast differentiation and bone formation

• 2002 BONE

  The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro

• 2004 BONE

  Interaction of estrogen receptor a with protein kinase C alpha and c-Src in osteoblasts during differentiation

• 2004 CALCIFIED TISSUE INTERNATIONAL

  Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations

• 2006 JOURNAL OF MEDICAL GENETICS

  Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment

• 2001 JOURNAL OF BONE AND MINERAL RESEARCH

  Apparent cure of a newborn with malignant osteopetrosis using prednisone therapy

• 2004 BONE

  In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells

• 2005 JOURNAL OF CELL SCIENCE

  A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alpha(V)beta(3) integrin in osteoclasts and in Chinese hamster ovary (CHO) cells

• 2003 AMERICAN JOURNAL OF PATHOLOGY

  Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis

• 2004 BONE

  Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway